Results 41 to 50 of about 1,343 (129)

Moldable and Particulate Bone Material in Alveolar Ridge Preservation: A Multicenter Randomized Controlled Trial

Clinical Implant Dentistry and Related Research, Volume 27, Issue 2, April 2025.
ABSTRACT Introduction This study aimed to determine possible histological and radiological differences in alveolar ridge preservation (ARP), using moldable bone versus particulate bone. Methods After tooth extraction, 39 patients (40 teeth) were randomized (1:1) to receive ARP using moldable bone materials (SBX group) or particulate bone materials (PBX
Yiseul Choi, Jieun Cheong, Yoolbin Song, Jaeyeon Kim, Dae‐Young Kang, Hyeon‐Seong Ahn, Sanghoon Park, Marco Esposito, Hyun‐Seung Shin, Wonse Park   +9 more
wiley   +1 more source

Usefulness of a New Therapy Using Rebamipide Eyedrops in Patients with VKC/AKC Refractory to Conventional Anti-Allergic Treatments

Allergology International, 2014
Background: Rebamipide, a gastroprotective drug, has been reported to suppress gastric mucosal inflammation. In Japan, rebamipide eyedrops have recently been approved for the treatment of dry eye disease. Some patients with allergic conjunctival diseases
Mayumi Ueta, Chie Sotozono, Ayaka Koga, Norihiko Yokoi, Shigeru Kinoshita   +4 more
doaj   +1 more source

Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology

Advanced Science, Volume 12, Issue 6, February 10, 2025.
A review of progress in nanotechnology for treating ocular surface chemical injuries. This is the most detailed review on the topic, serving as a microcosm of advancements in the application of nanotechnology in ophthalmology. It analyzes 12 nanocarrier platforms, namely liposomes, nanoemulsions, nanomicelles, nanowafers, nanostructured lipid carriers,
Qiaoran Qi, Dai Su, Shuqin Zhuang, Sunyuan Yao, Ludwig M. Heindl, Xianqun Fan, Ming Lin, Jin Li, Yan Pang   +8 more
wiley   +1 more source

Effect of Rebamipide on Fecal Helicobacter pylori Antigen Test [PDF]

Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aim: Fecal antigen testing for H. pylori is a non-invasive, cost-effective, and user-friendly diagnostic tool, particularly valuable for screening high-risk populations.
Mohamed Farouk, Ghada Saied, Helal Hetta, Mohammed Molla, Mohamed Sayed   +4 more
doaj   +1 more source

Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits. [PDF]

PLoS ONE, 2017
This study aimed to determine if rebamipide eyedrops can improve ocular surface damage caused by the use of glaucoma eyedrops.Female Kbl:Dutch rabbits were used to evaluate glaucoma eyedrop-induced ocular surface damage; one eye of each rabbit was ...
Ichiro Kawaguchi, Akira Kobayashi, Tomomi Higashide, Yasuhiro Takeji, Kazushi Sakurai, Chiaki Kawaguchi, Kazuhisa Sugiyama   +6 more
doaj   +1 more source

Therapeutic Controlled Release Strategies for Human Osteoarthritis

Advanced Healthcare Materials, Volume 14, Issue 2, January 14, 2025.
Therapeutic controlled release is a promising approach to treat the progressive and irreversible pathological changes in human osteoarthritis. This strategy is based on the application of recombinant molecules, drugs, and gene sequences via biocompatible materials and may provide effective and long‐lasting tools promoting the spatiotemporal delivery ...
Dan Wang, Wei Liu, Jagadeesh K. Venkatesan, Henning Madry, Magali Cucchiarini   +4 more
wiley   +1 more source

Cytoprotection of the Gastric Mucosa and Eradication Therapy of Helicobacter Pylori Infection: Points of Conjugation

Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to present data on the main components of gastric mucosal protection and the possibilities of H. pylori eradication and cytoprotective pharmacotherapy for its restoration.Key points.
A. S. Trukhmanov, D. E. Rumyantseva, T. L. Lapina   +2 more
doaj   +1 more source

The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis

Journal of Pharmaceutical Health Care and Sciences, 2019
Background Oral mucositis is a frequent and severe adverse event in patients undergoing chemoradiotherapy for head and neck cancers, especially grade 3 or 4 mucositis. Occurrence may result in drop-out from treatment, thereby reducing survival.
Shinsuke Akagi, Takashi Fujiwara, Mai Nishida, Akiko Okuda, Yuka Nagao, Toshikatsu Okuda, Hidenori Tokuda, Kazunobu Takayanagi   +7 more
doaj   +1 more source

Lower LEDD and Polypharmacy Rates Beyond the Honeymoon Period in Patients With Parkinson’s Disease Integrative Western–Korean Medicine Interventions: A CARE‐Compliant Case Series

Parkinson's Disease, Volume 2025, Issue 1, 2025.
Background Parkinson’s disease (PD) is the second most common neurodegenerative disorder with significant social costs, mainly owing to hospitalization, which is frequently associated with high levodopa equivalent daily dose (LEDD) and polypharmacy rather than neurological symptoms alone.
Cheol-Hyun Kim, Taeseok Ahn, Youngjo So, Hyeon-Gyu Cho, Jiwoo Kim, Jihyun Moon, Myungjin Oh, Sunny Kang, Sangho Ji, Linae Kim, Sangkwan Lee, Namkwen Kim, Cristine Alves da Costa   +12 more
wiley   +1 more source

Progress and Prospects in the Treatment of Lacrimal Gland Dysfunction Diseases: From Traditional Treatment Methods to Stem Cell and Organoid Therapies

Stem Cells International, Volume 2025, Issue 1, 2025.
Lacrimal gland (LG) dysfunction diseases are a type of disorder caused by various etiologies that damage the LG tissue, reducing lacrimal fluid secretion, triggering aqueous‐deficient dry eye (ADDE), and causing a series of complications like keratoconjunctivitis sicca, potentially threatening vision.
Xiaona Chen, Shixu Li, Yongxin Zhang, Lin Ye, Simona Ceccarelli   +4 more
wiley   +1 more source